{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:11:59Z","timestamp":1778299919476,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fondation Mont Godinne"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11096-024-01816-9","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T13:14:58Z","timestamp":1731330898000},"page":"136-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Appropriateness of intravenous fluid prescriptions in hospitalised patients: a point prevalence study"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-3499","authenticated-orcid":false,"given":"Barbara","family":"Sneyers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Nyssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Bulpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Michaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Lacrosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe E.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Rotens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"1816_CR1","unstructured":"Colin B. D\u00e9penses pour les sp\u00e9cialit\u00e9s pharmaceutiques \u00e0 l'h\u00f4pital. In: Monitoring of reimbursement: Significant expenses. Direction Politique Pharmaceutique. Service des Soins de Sant\u00e9. INAMI. 2021. https:\/\/www.inami.fgov.be\/SiteCollectionDocuments\/morse_rapport_donnees_2021.pdf. Accessed 1 Dec 2023."},{"key":"1816_CR2","unstructured":"National Institute for Health and Clinical Excellence. Intravenous Fluid Therapy in Adults in Hospital. CG: CG 174. In: Medicine Management Guidelines. 2013. https:\/\/www.nice.org.uk\/guidance\/cg174. Accessed 1 Dec 2023."},{"key":"1816_CR3","doi-asserted-by":"publisher","first-page":"g1262","DOI":"10.1136\/bmj.g1262","volume":"348","author":"S Yuan","year":"2014","unstructured":"Yuan S. China should reduce the overuse of intravenous infusion. BMJ. 2014;348:g1262. https:\/\/doi.org\/10.1136\/bmj.g1262.","journal-title":"BMJ"},{"issue":"4","key":"1816_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4266\/kjccm.2016.00934","volume":"31","author":"NJBR Glassford","year":"2016","unstructured":"Glassford NJBR. The complexities of intravenous fluid research: questions of scale, volume, and accumulation. Acute Crit Care. 2016;31(4):276\u201399. https:\/\/doi.org\/10.4266\/kjccm.2016.00934.","journal-title":"Acute Crit Care"},{"issue":"2","key":"1816_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1441-2772(23)01009-8","volume":"18","author":"NJ Glassford","year":"2016","unstructured":"Glassford NJ, French CJ, Bailey M, et al. Changes in intravenous fluid use patterns in Australia and New Zealand: evidence of research translating into practice. Crit Care Resusc. 2016;18(2):78\u201388.\u00a0https:\/\/doi.org\/10.1016\/S1441-2772(23)01009-8.","journal-title":"Crit Care Resusc"},{"key":"1816_CR6","unstructured":"Malbrain M. An introduction to fluid stewardship\u2014a Belgian perspective. In: 12th international fluid academy day and 9th Benelux emergency medicine symposium. International Fluid Academy. 2022. https:\/\/www.fluidacademy.org\/component\/zoo\/item\/an-introduction-to-fluid-stewardship-a-belgian-perspective.html. Accessed: 1 Dec 2023."},{"issue":"1","key":"1816_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/175114370901000105","volume":"10","author":"J Powell-Tuck","year":"2009","unstructured":"Powell-Tuck J, Allison SP, Gosling P, et al. Summary of the British consensus guidelines on intravenous fluid therapy for adult surgical patients (GIFTASUP)\u2014for comment. J Intensive Care Soc. 2009;10(1):13\u20135. https:\/\/doi.org\/10.1177\/175114370901000105.","journal-title":"J Intensive Care Soc"},{"issue":"2","key":"1816_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1054\/clnu.2000.0154","volume":"20","author":"DN Lobo","year":"2001","unstructured":"Lobo DN, Dube MG, Neal KR, et al. Problems with solutions: drowning in the brine of an inadequate knowledge base. Clin Nutr. 2001;20(2):125\u201330. https:\/\/doi.org\/10.1054\/clnu.2000.0154.","journal-title":"Clin Nutr"},{"issue":"2","key":"1816_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s11096-012-9620-8","volume":"34","author":"M Mousavi","year":"2012","unstructured":"Mousavi M, Khalili H, Dashti-Khavidaki S. Errors in fluid therapy in medical wards. Int J Clin Pharm. 2012;34(2):374\u201381. https:\/\/doi.org\/10.1007\/s11096-012-9620-8.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"1816_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jchf.2014.09.007","volume":"3","author":"B Bikdeli","year":"2015","unstructured":"Bikdeli B, Strait KM, Dharmarajan K, et al. Intravenous fluids in acute decompensated heart failure. JACC Heart Fail. 2015;3(2):127\u201333. https:\/\/doi.org\/10.1016\/j.jchf.2014.09.007.","journal-title":"JACC Heart Fail"},{"issue":"3","key":"1816_CR11","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.18549\/PharmPract.2019.3.1552","volume":"17","author":"SK Abbood","year":"2019","unstructured":"Abbood SK, Assad HC, Al-Jumaili AA. Pharmacist intervention to enhance postoperative fluid prescribing practice in an Iraqi hospital through implementation of NICE guideline. Pharm Pract (Granada). 2019;17(3):1552. https:\/\/doi.org\/10.18549\/PharmPract.2019.3.1552.","journal-title":"Pharm Pract (Granada)"},{"issue":"2","key":"1816_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1308\/147870805x28127","volume":"87","author":"SR Walsh","year":"2005","unstructured":"Walsh SR, Walsh CJ. Intravenous fluid-associated morbidity in postoperative patients. Ann R Coll Surg Engl. 2005;87(2):126\u201330. https:\/\/doi.org\/10.1308\/147870805x28127.","journal-title":"Ann R Coll Surg Engl"},{"issue":"12","key":"1816_CR13","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1097\/ccm.0000000000004617","volume":"48","author":"AS Messmer","year":"2020","unstructured":"Messmer AS, Zingg C, M\u00fcller M, et al. Fluid overload and mortality in adult critical care patients-a systematic review and meta-analysis of observational studies. Crit Care Med. 2020;48(12):1862\u201370. https:\/\/doi.org\/10.1097\/ccm.0000000000004617.","journal-title":"Crit Care Med"},{"issue":"2","key":"1816_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7326\/0003-4819-124-2-199601150-00002","volume":"124","author":"PM Palevsky","year":"1996","unstructured":"Palevsky PM, Bhagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med. 1996;124(2):197\u2013203. https:\/\/doi.org\/10.7326\/0003-4819-124-2-199601150-00002.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1816_CR15","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/archinte.160.10.1541","volume":"160","author":"HJ Milionis","year":"2000","unstructured":"Milionis HJ, Liamis G, Elisaf MS. Hypernatremia in hospitalized patients: a sequel of inadvertent fluid administration. Arch Intern Med. 2000;160(10):1541\u20132. https:\/\/doi.org\/10.1001\/archinte.160.10.1541.","journal-title":"Arch Intern Med"},{"issue":"8","key":"1816_CR16","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/ndt\/gfq067","volume":"25","author":"M Darmon","year":"2010","unstructured":"Darmon M, Timsit JF, Francais A, et al. Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transplant. 2010;25(8):2510\u20135. https:\/\/doi.org\/10.1093\/ndt\/gfq067.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1816_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/jcpt.12295","volume":"40","author":"X Gao","year":"2015","unstructured":"Gao X, Huang KP, Wu HY, et al. Inappropriate prescribing of intravenous fluid in adult inpatients-a literature review of current practice and research. J Clin Pharm Ther. 2015;40(5):489\u201395. https:\/\/doi.org\/10.1111\/jcpt.12295.","journal-title":"J Clin Pharm Ther"},{"key":"1816_CR18","doi-asserted-by":"publisher","first-page":"m3507","DOI":"10.1136\/bmj.m3507","volume":"370","author":"C Dyer","year":"2020","unstructured":"Dyer C. Hospital errors led to patient\u2019s death, finds coroner. BMJ. 2020;370:m3507. https:\/\/doi.org\/10.1136\/bmj.m3507.","journal-title":"BMJ"},{"issue":"1","key":"1816_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13256-021-02889-0","volume":"15","author":"M Denis","year":"2021","unstructured":"Denis M, Di Giacomo A, Lacotte E, et al. From hypotonic maintenance fluid to severe hyponatremia: a case report. J Med Case Rep. 2021;15(1):315. https:\/\/doi.org\/10.1186\/s13256-021-02889-0.","journal-title":"J Med Case Rep"},{"issue":"11","key":"1816_CR20","doi-asserted-by":"publisher","first-page":"e11765","DOI":"10.7759\/cureus.11765","volume":"12","author":"RA Bennett","year":"2020","unstructured":"Bennett RA, Fowler GE. Surgical fluid prescribing: When are the last orders? Cureus. 2020;12(11):e11765. https:\/\/doi.org\/10.7759\/cureus.11765.","journal-title":"Cureus"},{"issue":"4","key":"1816_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00134-018-5147-3","volume":"44","author":"N Van Regenmortel","year":"2018","unstructured":"Van Regenmortel N, Verbrugghe W, Roelant E, et al. Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective study in a tertiary mixed ICU population. Intensive Care Med. 2018;44(4):409\u201317. https:\/\/doi.org\/10.1007\/s00134-018-5147-3.","journal-title":"Intensive Care Med"},{"issue":"3","key":"1816_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1742-1241.2007.01386.x","volume":"62","author":"SR Walsh","year":"2008","unstructured":"Walsh SR, Cook EJ, Bentley R, et al. Perioperative fluid management: prospective audit. Int J Clin Pract. 2008;62(3):492\u20137. https:\/\/doi.org\/10.1111\/j.1742-1241.2007.01386.x.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"1816_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4997\/jrcpe.2012.304","volume":"42","author":"GE Walker","year":"2012","unstructured":"Walker GE, Stewart-Parker E, Chinthapalli S, et al. Intravenous fluid use in the acutely unwell adult medical inpatient: improving practice through a clinical audit process. J R Coll Physicians Edinb. 2012;42(3):211\u20135. https:\/\/doi.org\/10.4997\/jrcpe.2012.304.","journal-title":"J R Coll Physicians Edinb"},{"issue":"2","key":"1816_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/175045891102100203","volume":"21","author":"K Bosworth","year":"2011","unstructured":"Bosworth K, Findlay JM, Spencer S. Multidisciplinary education improves prescription of balanced crystalloids: a pilot study. J Perioper Pract. 2011;21(2):64\u20138. https:\/\/doi.org\/10.1177\/175045891102100203.","journal-title":"J Perioper Pract"},{"issue":"1","key":"1816_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13613-018-0402-x","volume":"8","author":"M Malbrain","year":"2018","unstructured":"Malbrain M, Van Regenmortel N, Saugel B, et al. Principles of fluid management and stewardship in septic shock: it is time to consider the four D\u2019s and the four phases of fluid therapy. Ann Intensive Care. 2018;8(1):66. https:\/\/doi.org\/10.1186\/s13613-018-0402-x.","journal-title":"Ann Intensive Care"},{"key":"1816_CR26","unstructured":"ASHP Injectable Drug Information [database on the Internet]. American Society of Health-System Pharmacists. 2022. https:\/\/www.medicinescomplete.com\/. Accessed 01 July 2022."},{"key":"1816_CR27","unstructured":"IBM Micromedex\u00ae DRUGDEX\u00ae [database on the Internet]. IBM Watson Health. 2022. https:\/\/www.micromedexsolutions.com\/. Accessed 01 July 2022."},{"issue":"5","key":"1816_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5603\/ait.2014.0060","volume":"46","author":"ML Malbrain","year":"2014","unstructured":"Malbrain ML, Marik PE, Witters I, et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014;46(5):361\u201380. https:\/\/doi.org\/10.5603\/ait.2014.0060.","journal-title":"Anaesthesiol Intensive Ther"},{"issue":"1","key":"1816_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/shk.0000000000000268","volume":"43","author":"DJ Kelm","year":"2015","unstructured":"Kelm DJ, Perrin JT, Cartin-Ceba R, et al. Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock. 2015;43(1):68\u201373. https:\/\/doi.org\/10.1097\/shk.0000000000000268.","journal-title":"Shock"},{"issue":"6","key":"1816_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/0897190019853979","volume":"33","author":"WA Hawkins","year":"2020","unstructured":"Hawkins WA, Smith SE, Newsome AS, et al. Fluid stewardship during critical illness: a call to action. J Pharm Pract. 2020;33(6):863\u201373. https:\/\/doi.org\/10.1177\/0897190019853979.","journal-title":"J Pharm Pract"},{"issue":"3","key":"1816_CR31","doi-asserted-by":"publisher","first-page":"e1135","DOI":"10.30968\/rbfhss.2024.153.1135","volume":"15","author":"EJ Cerqueira","year":"2024","unstructured":"Cerqueira EJ, Lima AM, Neto JA, et al. Fluid stewardship in intensive care: clinical pharmacist\u2019s actions analysis. Rev Bras Farm Hosp Serv Sa\u00fade. 2024;15(3):e1135. https:\/\/doi.org\/10.30968\/rbfhss.2024.153.1135.","journal-title":"Rev Bras Farm Hosp Serv Sa\u00fade"},{"issue":"12","key":"1816_CR32","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/ajhp\/zxab453","volume":"79","author":"WA Hawkins","year":"2022","unstructured":"Hawkins WA, Butler SA, Poirier N, et al. From theory to bedside: implementation of fluid stewardship in a medical ICU pharmacy practice. Am J Health Syst Pharm. 2022;79(12):984\u201392. https:\/\/doi.org\/10.1093\/ajhp\/zxab453.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"1816_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13613-019-0607-7","volume":"9","author":"A Lind\u00e9n-S\u00f8nders\u00f8","year":"2019","unstructured":"Lind\u00e9n-S\u00f8nders\u00f8 A, Jungner M, Sp\u00e5ngfors M, et al. Survey of non-resuscitation fluids administered during septic shock: a multicenter prospective observational study. Ann Intensive Care. 2019;9(1):132. https:\/\/doi.org\/10.1186\/s13613-019-0607-7.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"1816_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00134-016-4573-3","volume":"43","author":"JA Silversides","year":"2016","unstructured":"Silversides JA, Major E, Ferguson AJ, et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 2016;43(2):155\u201370. https:\/\/doi.org\/10.1007\/s00134-016-4573-3.","journal-title":"Intensive Care Med"},{"key":"1816_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40560-020-00489-6","volume":"8","author":"Y Aoyagi","year":"2020","unstructured":"Aoyagi Y, Yoshida T, Uchino S, et al. Saline versus 5% dextrose in water as a drug diluent for critically ill patients: a retrospective cohort study. J Intensive Care. 2020;8:69. https:\/\/doi.org\/10.1186\/s40560-020-00489-6.","journal-title":"J Intensive Care"},{"issue":"3","key":"1816_CR36","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jcrc.2014.01.025","volume":"29","author":"WP Choo","year":"2014","unstructured":"Choo WP, Groeneveld AB, Driessen RH, et al. Normal saline to dilute parenteral drugs and to keep catheters open is a major and preventable source of hypernatremia acquired in the intensive care unit. J Crit Care. 2014;29(3):390\u20134. https:\/\/doi.org\/10.1016\/j.jcrc.2014.01.025.","journal-title":"J Crit Care"},{"key":"1816_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jcrc.2018.10.025","volume":"49","author":"T Maes","year":"2019","unstructured":"Maes T, Meuwissen A, Diltoer M, et al. Impact of maintenance, resuscitation and unintended fluid therapy on global fluid load after elective coronary artery bypass surgery. J Crit Care. 2019;49:129\u201335. https:\/\/doi.org\/10.1016\/j.jcrc.2018.10.025.","journal-title":"J Crit Care"},{"key":"1816_CR38","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3039","author":"E Alexandrou","year":"2018","unstructured":"Alexandrou E, Ray-Barruel G, Carr PJ, et al. Use of short peripheral intravenous catheters: characteristics, management, and outcomes worldwide. J Hosp Med. 2018. https:\/\/doi.org\/10.12788\/jhm.3039.","journal-title":"J Hosp Med"},{"issue":"10","key":"1816_CR39","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1016\/j.ajic.2016.03.073","volume":"44","author":"MB Becerra","year":"2016","unstructured":"Becerra MB, Shirley D, Safdar N. Prevalence, risk factors, and outcomes of idle intravenous catheters: an integrative review. Am J Infect Control. 2016;44(10):e167\u201372. https:\/\/doi.org\/10.1016\/j.ajic.2016.03.073.","journal-title":"Am J Infect Control"},{"key":"1816_CR40","doi-asserted-by":"publisher","DOI":"10.2471\/B09039","volume-title":"Guidelines for the prevention of bloodstream infections and other infections associated with the use of intravascular catheters. Part I: peripheral catheters","author":"World Health Organization","year":"2024","unstructured":"World Health Organization\u00a0 Guideline Review Comitee Infection Prevention and Control.\u00a0Part I: peripheral catheters. In: Guidelines for the prevention of bloodstream infections and other infections associated with the use of intravascular catheters. World Health Organization. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240093829. Accessed 1 Jun 2024."},{"issue":"2","key":"1816_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jcjq.2019.10.004","volume":"46","author":"M Quinn","year":"2020","unstructured":"Quinn M, Ameling JM, Forman J, et al. Persistent barriers to timely catheter removal identified from clinical observations and interviews. Jt Comm J Qual Patient Saf. 2020;46(2):99\u2013108. https:\/\/doi.org\/10.1016\/j.jcjq.2019.10.004.","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"10","key":"1816_CR42","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/jp.2016.94","volume":"36","author":"D Stok","year":"2016","unstructured":"Stok D, Wieringa JW. Continuous infusion versus intermittent flushing: maintaining peripheral intravenous access in newborn infants. J Perinatol. 2016;36(10):870\u20133. https:\/\/doi.org\/10.1038\/jp.2016.94.","journal-title":"J Perinatol"},{"issue":"4","key":"1816_CR43","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1515\/jpm-2018-0285","volume":"47","author":"R Hoff","year":"2019","unstructured":"Hoff R, Vervisch K, De Coen K, et al. Continuous infusion vs. intermittent flushing of peripheral cannulas in neonates using a needleless connector: a prospective cohort study. J Perinat Med. 2019;47(4):464\u20139. https:\/\/doi.org\/10.1515\/jpm-2018-0285.","journal-title":"J Perinat Med"},{"key":"1816_CR44","doi-asserted-by":"publisher","first-page":"796762","DOI":"10.1155\/2015\/796762","volume":"2015","author":"NL Moureau","year":"2015","unstructured":"Moureau NL, Flynn J. Disinfection of needleless connector hubs: clinical evidence systematic review. Nurs Res Pract. 2015;2015:796762. https:\/\/doi.org\/10.1155\/2015\/796762.","journal-title":"Nurs Res Pract"},{"issue":"5","key":"1816_CR45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/qhc.12.5.343","volume":"12","author":"K Taxis","year":"2003","unstructured":"Taxis K, Barber N. Causes of intravenous medication errors: an ethnographic study. Qual Saf Health Care. 2003;12(5):343\u20137. https:\/\/doi.org\/10.1136\/qhc.12.5.343.","journal-title":"Qual Saf Health Care"},{"key":"1816_CR46","volume-title":"Safe practice guidelines for adult IV Push medications","author":"ISMP","year":"2015","unstructured":"Institute for Safe Medication Practices (ISMP). Safe practice guidelines for adult IV Push medications. In: ISMP guidance and tools. Institute for Safe Medication Practices. 2015. https:\/\/www.ismp.org\/sites\/default\/files\/attachments\/2017-11\/ISMP97-Guidelines-071415-3.%20FINAL.pdf. Accessed 1 Dec 2023."},{"issue":"9","key":"1816_CR47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/ajhp\/zxaa044","volume":"77","author":"K Marsh","year":"2020","unstructured":"Marsh K, Ahmed N, Decano A, et al. Safety of intravenous push administration of beta-lactams within a healthcare system. Am J Health Syst Pharm. 2020;77(9):701\u20138. https:\/\/doi.org\/10.1093\/ajhp\/zxaa044.","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"1816_CR48","doi-asserted-by":"publisher","first-page":"ofac117","DOI":"10.1093\/ofid\/ofac117","volume":"9","author":"KJ Yagnik","year":"2022","unstructured":"Yagnik KJ, Brown LS, Saad HA, et al. Implementation of IV push antibiotics for outpatients during a national fluid shortage following Hurricane Maria. Open Forum Infect Dis. 2022;9(5):ofac117. https:\/\/doi.org\/10.1093\/ofid\/ofac117.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"1816_CR49","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/00185787211046854","volume":"57","author":"AC Faust","year":"2022","unstructured":"Faust AC, Schwaner L, Thomas D, et al. Pre-endoscopy use of proton pump inhibitor intravenous bolus dosing in hemodynamically stable patients with suspected upper gastrointestinal bleeding: results of a pharmacist-managed hospital protocol to reduce continuous infusion pantoprazole use. Hosp Pharm. 2022;57(4):448\u201354. https:\/\/doi.org\/10.1177\/00185787211046854.","journal-title":"Hosp Pharm"},{"issue":"6","key":"1816_CR50","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/phar.2687","volume":"42","author":"A Jense","year":"2022","unstructured":"Jense A, Douville A, Weiss A. The safety of rapid infusion levetiracetam: a systematic review. Pharmacotherapy. 2022;42(6):495\u2013503. https:\/\/doi.org\/10.1002\/phar.2687.","journal-title":"Pharmacotherapy"},{"key":"1816_CR51","doi-asserted-by":"publisher","DOI":"10.1177\/08971900211061937","author":"MA Alrashed","year":"2022","unstructured":"Alrashed MA, Kang N, Perona SJ, et al. Evaluation of intravenous push piperacillin\u2013tazobactam on time to antibiotic administration in emergency department patients with sepsis. J Pharm Pract. 2022. https:\/\/doi.org\/10.1177\/08971900211061937.","journal-title":"J Pharm Pract"},{"issue":"3","key":"1816_CR52","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12028-018-0560-6","volume":"29","author":"KE Davidson","year":"2018","unstructured":"Davidson KE, Newell J, Alsherbini K, et al. Safety and efficiency of intravenous push lacosamide administration. Neurocrit Care. 2018;29(3):491\u20135. https:\/\/doi.org\/10.1007\/s12028-018-0560-6.","journal-title":"Neurocrit Care"},{"key":"1816_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ajem.2020.03.022","volume":"43","author":"A Agunbiade","year":"2021","unstructured":"Agunbiade A, Routsolias JC, Rizvanolli L, et al. The effects of ceftriaxone by intravenous push on adverse drug reactions in the emergency department. Am J Emerg Med. 2021;43:245\u20138. https:\/\/doi.org\/10.1016\/j.ajem.2020.03.022.","journal-title":"Am J Emerg Med"},{"issue":"3","key":"1816_CR54","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s12028-021-01237-w","volume":"35","author":"T Adams","year":"2021","unstructured":"Adams T, Greathouse K. Evaluation of time to administration, benzodiazepine use, and safety of intravenous push levetiracetam in a neuro-spine intensive care unit. Neurocrit Care. 2021;35(3):789\u201393. https:\/\/doi.org\/10.1007\/s12028-021-01237-w.","journal-title":"Neurocrit Care"},{"issue":"8","key":"1816_CR55","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/ccm.0000000000004430","volume":"48","author":"AJ Gregorowicz","year":"2020","unstructured":"Gregorowicz AJ, Costello PG, Gajdosik DA, et al. Effect of IV push antibiotic administration on antibiotic therapy delays in sepsis. Crit Care Med. 2020;48(8):1175\u20139. https:\/\/doi.org\/10.1097\/ccm.0000000000004430.","journal-title":"Crit Care Med"},{"issue":"2","key":"1816_CR56","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2165\/00019053-199201020-00008","volume":"1","author":"JC Garrelts","year":"1992","unstructured":"Garrelts JC, Smith DF, Ast D, et al. A comparison of the safety, timing and cost-effectiveness of administering antibiotics by intravenous bolus (push) versus intravenous piggyback (slow infusion) in surgical prophylaxis. Pharmacoeconomics. 1992;1(2):116\u201323. https:\/\/doi.org\/10.2165\/00019053-199201020-00008.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1816_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/reveh-2012-0030","volume":"28","author":"EJ North","year":"2013","unstructured":"North EJ, Halden RU. Plastics and environmental health: the road ahead. Rev Environ Health. 2013;28(1):1\u20138. https:\/\/doi.org\/10.1515\/reveh-2012-0030.","journal-title":"Rev Environ Health"},{"issue":"3","key":"1816_CR58","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/pts.0000000000000269","volume":"15","author":"M Burger","year":"2019","unstructured":"Burger M, Degnan D. Comparative safety, efficiency, and nursing preference among 3 methods for intravenous push medication preparation: a randomized crossover simulation study. J Patient Saf. 2019;15(3):238\u201345. https:\/\/doi.org\/10.1097\/pts.0000000000000269.","journal-title":"J Patient Saf"},{"key":"1816_CR59","doi-asserted-by":"publisher","first-page":"100012","DOI":"10.1016\/j.rcsop.2021.100012","volume":"2","author":"M Kurttila","year":"2021","unstructured":"Kurttila M, Saano S, Laaksonen R. Describing voluntarily reported fluid therapy incidents in the care of critically ill patients: identifying, and learning from, points of risk at the national level. Explor Res Clin Soc Pharm. 2021;2:100012. https:\/\/doi.org\/10.1016\/j.rcsop.2021.100012.","journal-title":"Explor Res Clin Soc Pharm"},{"key":"1816_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/bmjquality.u205899.w2409","author":"LT Sansom","year":"2014","unstructured":"Sansom LT, Duggleby L. Intravenous fluid prescribing: Improving prescribing practices and documentation in line with NICE CG174 guidance. BMJ Qual Improv Rep. 2014. https:\/\/doi.org\/10.1136\/bmjquality.u205899.w2409.","journal-title":"BMJ Qual Improv Rep"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01816-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T19:43:25Z","timestamp":1737143005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01816-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1816"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01816-9","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare there are no conflicts of interest regarding the present work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}